NewYork-Presbyterian Hospital and Columbia University Medical Center today announced the dedication of the Avon Foundation Breast Imaging Center and the Avon Breast Cancer Research Laboratories -- two key components of the Avon Foundation Breast Cancer Program, supported by gifts from the Avon Foundation totaling $16 million since 2000.

Ongoing hassles at work are a real threat to health because they can raise blood pressure over the long term... right? Wrong. While no one disagrees that a fight with the boss can send blood pressure skywards for an hour or so, the most comprehensive review of the literature on the subject ever conducted finds little evidence that day-to-day work woes affect chronic blood pressure, one way or the other.

An electrocardiogram (ECG) is an effective tool for detecting risk of congestive heart failure (CHF) in patients with hypertension, according to a new study by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and published in today's journal Circulation: Journal of the American Heart Association. The findings may help increase early detection and treatment of CHF.

UNIVISION/Channel 41 celebrated health week from August 23-30. As part of this health initiative (and in collaboration with NYP) the network hosted a town hall on women’s health on Friday, August 29, in the Myrna L. Daniels Auditorium and the Riverview Terrace.

A renowned expert in outcomes research and evidence-based medicine in otolaryngology (ear, nose, and throat -- or ENT), Dr. Michael G. Stewart has been appointed Chairman of the Department of Otorhinolaryngology at Weill Medical College of Cornell University and Otorhinolaryngologist-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Stewart was previously affiliated with Baylor College of Medicine and several institutions in the Texas Medical Center in Houston.

Katie Couric, NewYork-Presbyterian Hospital and its Jay Monahan Center for Gastrointestinal Health, and the Entertainment Industry Foundation’s National Colorectal Cancer Research Alliance want you to “make that call” to your doctor for colon cancer screening if you are 50 or older or otherwise at high risk for colon cancer.

NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical centers participating in a clinical trial of a new device for advanced heart failure patients, the Thoratec® HeartMate III Left Ventricular Assist System (LVAS). The device is designed to supplement the heart’s pumping function in patients with left-sided heart failure.

Colon cancer, the second-leading cause of cancer death in the United States, is often preventable and highly curable.